QS/1 Partners with Veridikal to Offer Reconciliation Programs

Article

PRESS RELEASE

Spartanburg, SC (September 8, 2014) — QS/1 is proud to announce it now offers Veridikal Intelligence and Veridikal’s Reconciliation program to its pharmacies. The program includes Pre/Post Editing, EDI support, 835 processing, Forensic Auditing and Reconciliation. This type of reconciliation program helps pharmacies eliminate many errors before claims are processed, which increases payments and speeds up prescription delivery to customers.

“Pre- and Post-Edits service evaluates prescription claims for omissions, errors and compliance with industry standards and metrics,” said Revonda Spratt, QS/1 Vice President, Operations. “This prevents the pharmacy from submitting a claim the insurance provider would reject due to missing or inaccurate information, and decreases the possibility of paying multiple submission charges on a single prescription.”

The Veridikal business edits program provides additional analysis of claims before they are sent to the third party, reducing the number of errors before the claim is processed to ensure revenue enhancements and reducing the amount of time pharmacy staff spends correcting rejected claims.

“Business Edit training and support are provided to all customers,” said Larry Lane, Veridikal Senior Vice President of Marketing. “The pharmacy staff also has the ability to access Veridikal University’s comprehensive training program designed to meet the staff’s schedule and apply for continuing education.”

Current QS/1 customers interested in Veridikal should contact Database Services at 800.845.7558, extension 1424

Related Videos
Semaglutide Ozempic injection control blood sugar levels | Image Credit: myskin - stock.adobe.com
Image credit: motortion | stock.adobe.com - Young depressed woman talking to lady psychologist during session, mental health
Image credit:  JPC-PROD | stock.adobe.com - Choosing method of contraception : Birth control pills, an injection syringe, condom, IUD-method, on grey
Semaglutide Ozempic injection control blood sugar levels | Image Credit: myskin - stock.adobe.com
Health care provider examining MRI images of patient with multiple sclerosis -- Image credit: New Africa | stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.